Market Research Industry Reports

Wellcome Trust - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Wellcome Trust is a charity that funds research organizations and research communities. The Trusts services include funding, grant management, education resources, and investment services. It offers its education services for PhD students, post-docs and clinicians, and practical and interactive training in the biomedical laboratory techniques and data-analysis tools. Wellcome Trust offers funding schemes to support individual researchers, teams and resources. The organization provides funds in areas of biomedical science, public engagement, humanities, innovations, social science, and other strategies. It serves individuals, hospitals, medical facilities, industrial and public sectors. Wellcome Trust is headquartered in London, the UK.

Wellcome Trust - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Wellcome Trust, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Wellcome Trust, Medical Devices Deals, 2012 to YTD 2018 11
Wellcome Trust, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Wellcome Trust, Pharmaceuticals & Healthcare, Deal Details 15
Venture Financing 15
Corinnova Raises USD6.1 Million from Wellcome Trust 15
Azellon Raises USD2 Million in Venture Financing 16
Kymab Raises USD100.5 Million in Series C Financing 18
Achilles Therapeutics Secures USD17.5 Million in Venture Financing Round Led by Syncona Partners 20
Achilles Therapeutics Raises USD17 Million in Venture Financing 21
Cambridge Epigenetix Raises USD21 Million in Series B Financing 22
Freeline Therapeutics to Raise USD38 Million in Series A Financing 23
NightstaRx Raises USD35 Million in Series B Financing Round 24
Nabriva Therapeutics Raises USD120 Million in Series B Financing 25
Nightstar Raises Additional USD8.2 Million in Venture Financing Round 27
Autolus Raises USD45.4 Million in Series A Financing 28
14M Genomics Raises USD19.6 Million in Venture Financing 29
Cambridge Epigenetix Raises USD5.5 Million in Series A Venture Financing 30
Kymab Raises USD40 Million in Series B Financing 31
Blue Earth Diagnostics Raises US$21.3 Million In Venture Financing 32
NightstaRx Raises US$19.8 Million In Venture Financing 33
Pcovery Raises USD4 Million in Venture Financing 34
Biocartis Raises US$40.5 Million In Series E Financing 35
Pcovery Raises USD5.7 Million in Seed Financing 37
Trino Therapeutics Raises US$12 Million In Series A Financing 38
Canbex Therapeutics Raises US$3 Million In Venture Financing 40
Partnerships 41
Sigma-Aldrich Enters into Agreement with Sanger Institute 41
AstraZeneca Enters into Research Agreement with Wellcome Trust Sanger Institute 42
UCL Business Forms Joint Venture with Syncona 43
Merck Serono Enters into Co-Development Agreement with Institute of Cancer Research and Wellcome Trust 44
Katholieke Universiteit Leuven And Wellcome Trust Enter Into Agreement With Janssen Pharma To Develop Dengue Antiviral Drugs 45
Licensing Agreements 47
Basilea Pharma Enters into Licensing Agreement for Novel PanRAF Kinase Inhibitors 47
Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute 48
Equity Offering 49
Microbiotica Spin Off from Wellcome Trust Sanger Institute 49
Debt Offering 50
Karuna Pharma Raises USD3.4 Million in Private Placement of Notes 50
Acquisition 51
Ergomed Acquires Haemostatix 51
GlaxoSmithKline Acquires Remaining Stake in GlycoVaxyn for USD190 Million 53
Wellcome Trust - Key Competitors 55
Wellcome Trust - Key Employees 56
Wellcome Trust - Locations And Subsidiaries 57
Head Office 57
Other Locations & Subsidiaries 57
Joint Venture 57
Recent Developments 59
Government and Public Interest 59
Dec 11, 2017: Scientists discover new way to help nerve regeneration in spinal cord injury 59
Dec 08, 2017: 3.9m project to support elimination of the worlds leading infectious cause of blindness 60
Nov 15, 2017: Improving clinical trials with machine learning 62
Oct 31, 2017: GHIT Fund Accelerates Promising Efforts to Find New Treatments, Vaccines and Diagnostics for Malaria, Tuberculosis, Leishmaniasis and Mycetoma 63
Sep 15, 2017: Exciting discovery on path to develop new type of vaccine to treat global viruses 66
Aug 30, 2017: Tracing single brain cancer cells simplifies complexity of incurable brain cancers, suggesting new treatments, international study finds 68
Aug 07, 2017: CARB-X Funds Scientists Discovering New Antibiotics to Treat Deadly Superbugs 70
Jan 16, 2017: Cancer genetics refine treatment decisions 72
Other Significant Developments 74
Mar 28, 2018: As the GHIT Fund Closes Out First Five Years of R&D for Lifesaving Medical Breakthroughs, It Launches Next Phase, Focusing on Access and Delivery, Bringing Total Investment to 13.2 Billion Yen (US$123 Million) 74
Dec 07, 2017: New mental health research framework announced 77
Appendix 78
Methodology 78
About GlobalData 78
Contact Us 78
Disclaimer 78

List Of Tables

List of Tables
Wellcome Trust, Pharmaceuticals & Healthcare, Key Facts 2
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Wellcome Trust, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Wellcome Trust, Deals By Therapy Area, 2012 to YTD 2018 10
Wellcome Trust, Medical Devices Deals, 2012 to YTD 2018 11
Wellcome Trust, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Corinnova Raises USD6.1 Million from Wellcome Trust 15
Azellon Raises USD2 Million in Venture Financing 16
Kymab Raises USD100.5 Million in Series C Financing 18
Achilles Therapeutics Secures USD17.5 Million in Venture Financing Round Led by Syncona Partners 20
Achilles Therapeutics Raises USD17 Million in Venture Financing 21
Cambridge Epigenetix Raises USD21 Million in Series B Financing 22
Freeline Therapeutics to Raise USD38 Million in Series A Financing 23
NightstaRx Raises USD35 Million in Series B Financing Round 24
Nabriva Therapeutics Raises USD120 Million in Series B Financing 25
Nightstar Raises Additional USD8.2 Million in Venture Financing Round 27
Autolus Raises USD45.4 Million in Series A Financing 28
14M Genomics Raises USD19.6 Million in Venture Financing 29
Cambridge Epigenetix Raises USD5.5 Million in Series A Venture Financing 30
Kymab Raises USD40 Million in Series B Financing 31
Blue Earth Diagnostics Raises US$21.3 Million In Venture Financing 32
NightstaRx Raises US$19.8 Million In Venture Financing 33
Pcovery Raises USD4 Million in Venture Financing 34
Biocartis Raises US$40.5 Million In Series E Financing 35
Pcovery Raises USD5.7 Million in Seed Financing 37
Trino Therapeutics Raises US$12 Million In Series A Financing 38
Canbex Therapeutics Raises US$3 Million In Venture Financing 40
Sigma-Aldrich Enters into Agreement with Sanger Institute 41
AstraZeneca Enters into Research Agreement with Wellcome Trust Sanger Institute 42
UCL Business Forms Joint Venture with Syncona 43
Merck Serono Enters into Co-Development Agreement with Institute of Cancer Research and Wellcome Trust 44
Katholieke Universiteit Leuven And Wellcome Trust Enter Into Agreement With Janssen Pharma To Develop Dengue Antiviral Drugs 45
Basilea Pharma Enters into Licensing Agreement for Novel PanRAF Kinase Inhibitors 47
Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute 48
Microbiotica Spin Off from Wellcome Trust Sanger Institute 49
Karuna Pharma Raises USD3.4 Million in Private Placement of Notes 50
Ergomed Acquires Haemostatix 51
GlaxoSmithKline Acquires Remaining Stake in GlycoVaxyn for USD190 Million 53
Wellcome Trust, Key Competitors 55
Wellcome Trust, Key Employees 56
Wellcome Trust, Subsidiaries 57
Wellcome Trust, Joint Venture 57

List Of Figures

List of Figures
Wellcome Trust, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Wellcome Trust, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Wellcome Trust, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Wellcome Trust, Medical Devices Deals, 2012 to YTD 2018 11

Wellcome Trust - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Wellcome Trust (Wellcome) is a charity that funds research organizations and research communities. It offers funding schemes to support individual researchers, teams and resources. The trust provides funds in areas

USD 250View Report

Wellcome Trust Sanger Institute - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Wellcome Trust Sanger Institute (Sanger Institute), a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular

USD 250View Report

Wellcome Trust - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Wellcome Trust (Wellcome) is a charity that funds research organizations and research communities. It offers funding schemes to support individual researchers, teams and resources. The trust provides funds in areas

USD 250View Report

Wellcome Trust Sanger Institute - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Wellcome Trust Sanger Institute (Sanger Institute), a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :78
Country :United Kingdom
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube